Attention-deficit/hyperactivity disorder-alternative treatment strategies;Hyperkinetische störungen-pharmakotherapeutische alternativen zu stimulanzien

Psychopharmakotherapie

Volumn 8, Issue 2, 2001, Pages 63-70

  Hassler F ^a   Buchmann, J ^a   Gohre C ^a   Fegert, J M ^a  

^a Jugendpsychiatrie Psychotherapie   (Germany)

Author keywords

Alternative medication; Attention deficit; Hyperactivity disorder; Psychopharmacology

Indexed keywords

ATOMOXETINE; BUSPIRONE; CENTRAL STIMULANT AGENT; RISPERIDONE;

ALTERNATIVE MEDICINE; ATTENTION DEFICIT DISORDER; DRUG EFFICACY; DRUG TOLERABILITY; HYPERACTIVITY; MENTAL DEFICIENCY; PREVALENCE; REVIEW; SCHOOL CHILD;

EID: 0034986648     PISSN: 09446877     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD
2. Open-label trial of venlafaxine in adults with attention deficit disorder
3. Prediction of clinical response in children taking methylphenidate
4. Increased 5-HAT release mediates the anxiogenic response benzodiazepine withdrawal: A review of supporting neurochemical and behavioral evidence
5. Beta blockers in mental retardation and developmental disorders
6. Pharmacological differentiation of classical and novel antipsychotics
7. A controlled trial of haloperidol in children
8. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder
9. Estimation of the association between desipramine and the risk for sudden death in 5 to 14 year old children
10. Pharmacotherapy of attention-deficit/hyperactivity disorder risk for substance use disorder
11. Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder
12. Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects
13. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose
14. 1A receptor agonists and subtypes of alpha-l-adrenoreceptors on rabbit aorta
15. Bupropion hydrochloride in attention deficit disorder with hyperactivity
16. Beta blockers for aggression: A review of the pediatric experience
17. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder
18. Adult treatment with haloperidol increases dentate granule cell proliferation in the gerbil hippocampus
19. Risperidone in young children with pervasive developmental disorders and other developmental disabilities
20. Die geschichte der neuroleptika
21. Predicting methylphenidate response in children with ADHD: Theoretical, empirical, and conceptual models
22. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD
23. Treatment of attention-deficit-hyperactivity disorder
24. Fachverbände für kinder- und jugendpsychiatrie und psychotherapie. Stellungnahmen der fachverbände für kinder- und jugendpsychiatrie und psychotherapie in deutschland zur behandlung hyperkinetischer störungen im kindesalter mit methylphenidat (Ritalin®)
25. Rechtliche fragen und notwendigkeiten der patienten-und elternaufklärung beim einsatz atypischer neuroleptika in der jugendpsychiatrie
26. Atypische neuroleptika in der jugendpsychiatrie
27. Venlafaxine in adults with attention deficit/hyperactivity disorder an open clinical trial
28. A double-blind placebo-controlled study of the efficacy of transdermal clonidine in autism
29. Antidepressiva
30. Pediatric psychopharmacotherapy: A review of recent research
31. Efficacy of methytphenidate for attention-deficit hyperactivity disorder in children with tic disorder
32. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms
33. The treatment of attention-deficit hyperactivity disorder with nonstimulant medications
34. Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
35. Buspirone in ADHD with ODD
36. Erfassung des hyperkinetischen syndroms bei erwachsenen
37. Hyperkinetische kinder-möglichkeiten und grenzen einer medikamentösen behandlung
38. Adverse side effects of methylphenidate among mentally retarded children with ADHD
39. Case study: Risperidone treatment of children and adolescents with developmental disorders
40. Buspirone - An alternative treatment of ADHD
41. An open trial of venlafaxin in adult patient with attention hyperactivity disorder
42. Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial
43. Treatment effects of oral and transdermal clonidine in relation to methylphenidate: An open pilot study in ADD-H
44. Clonidine treatment of hyperactive and impulsive children with autistic disorder
45. Effects of late-afternoon methylphenidate administration on behavior and sleep ill attention-deficit hyperactivity disorder
46. Psychomotor impairment and cognitive disturbances induced by neuroleptics
47. Die stimulantienbehandlung bet kindern
48. Ethische prinzipien für klinische prüfungen bei kindern und jugendlichen
49. Das hyperkinetische syndrom (Aufmerksamkeitsdefizit /Hyperaktivitätsstörung) des erwachsenenalters
50. Hyperkinetisches syndrom: Aktivitäts-/aufmerksamkeitsstörung
51. Clonidine treatment of Gilles de la Tourette's syndrome
52. An open clinical trial of buspirone in children with attention-deficit/hyperactivity disorder
53. A pilot study of buspirone in attention-deficit hyperactivity disorder
54. Drugs in management of minimal brain dysfunction
55. Atypische neuroleptika: Definitionsprobleme, Wirkungsmechanismen
56. National Institutes of Health consensus development conference statement: Diagnosis and treatment of ADHD
57. Paul Janssen und die entdeckung von haloperidol sowie anderer neuroleptika
58. Side effects of methylphenidate and desipramine alone and in combination in children
59. Catecholamines in attention-deficit hyperactivity disorder: Current perspectives
60. Zur behandlung des hyperkinetischen syndroms (HKS) mit stimuhmzien
61. Childhood behavior and learning problems treated with imipramine
62. Playroom observation of hyperactive children on medication
63. Methylphenidate and desipramine in hospitalized children: Seperate and combined effects on cognitive function
64. Das hyperkinetische syndrom im kindesalter
65. An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder
66. Observation on effects of a central stimulant drug in children with hyperactive behavior
67. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: Case reports and literature review
68. Der stellenwert typischer und atypischer neuroleptika
69. Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: Preliminary findings in a children's inpatient unit
70. Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity
71. Risperidone effects in treatment-resistant adolescents: Preliminary case reports
72. The treatment of attention-defict hyperactivity disorder in Tourette's syndrome: A double-blind placebo-controlled study with clonidine and desipramine
73. Tricyclic antidepressant treatment of hyperactivity
74. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle
75. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder
76. Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD
77. Hyperkinetische störungen - Eine klinische einführung
78. Debate: Combining methylphenidate and clonidine: Ill-advised
79. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety
80. Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour
81. Wirksamkeit und verträglichkeit des selektiven MAO-A-inhibitors moclobemid bei kindern mit hyperkinetischem syndrom
82. Modification by propranolol and related compounds of motor activity and stereotyped behaviour induced in the rat by amphetamine
83. Comparison of the effect of chlorpromazine, dextroamphetamine and methylphenidate on the behavior and intellectual functioning of hyperactive children
84. Bupropion treatment of attention-deficit hyperactivity disorder in adults
85. Debate: Combining methylphenidate and clonidine: A clinically sound medication option
86. Body growth and cardiovascular function after extended treatment (1.75 years) with methylphenidate in boys with attention-deficit hyperactivity disorder
87. Buspirone use in an adolescent with social phobia and mixed personality disorder (cluster A type)